An observational prospective study to determine the impact of foam sclerotherapy of large, dominant kidney/liver cysts on quality of life outcomes and kidney/liver cyst volumes at up to 12 months of follow-up in patients with autosomal dominant polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease (ADPLD).
Age ≥18 years
Clinical diagnosis of ADPKD or ADPLD
1-3 large, non-exophytic liver or kidney cyst
Compressive symptoms from dominant cyst
Age <18 years
Absence of ADPKD or ADPLD
Largest cyst <4cm in all 3 dimensions or largest cyst volume <400cc
>3 large, non-exophytic liver or kidney cyst(s) ≥4cm in all 3 dimensions (cyst volume ≥400cc)